{
    "topic": "coronavirus",
    "source": "BBC News",
    "bias": 1,
    "url": "https://www.bbc.com/news/health-53061281",
    "title": "Coronavirus: Dexamethasone proves first life-saving drug",
    "date": "",
    "authors": "Michelle Roberts",
    "content": "A cheap and widely available drug can help save the lives of patients seriously ill with coronavirus .\nThe low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus , UK experts say .\nThe drug is part of the world 's biggest trial testing existing treatments to see if they also work for coronavirus .\nIt cut the risk of death by a third for patients on ventilators . For those on oxygen , it cut deaths by a fifth .\nHad the drug had been used to treat patients in the UK from the start of the pandemic , up to 5,000 lives could have been saved , researchers say .\nAnd it could be of huge benefit in poorer countries with high numbers of Covid-19 patients .\nThe UK government has 200,000 courses of the drug in its stockpile and says the NHS will make dexamethasone available to patients .\nPrime Minister Boris Johnson said there was a genuine case to celebrate `` a remarkable British scientific achievement '' , adding : `` We have taken steps to ensure we have enough supplies , even in the event of a second peak . ''\nChief Medical Officer for England Prof Chris Whitty said it would save lives around the world .\nAbout 19 out of 20 patients with coronavirus recover without being admitted to hospital .\nOf those who are admitted , most also recover but some may need oxygen or mechanical ventilation .\nAnd these are the high-risk patients dexamethasone appears to help .\nThe drug is already used to reduce inflammation in a range of other conditions , including arthritis , asthma and some skin conditions .\nAnd it appears to help stop some of the damage that can happen when the body 's immune system goes into overdrive as it tries to fight off coronavirus .\nIn the trial , led by a team from Oxford University , about 2,000 hospital patients were given dexamethasone and compared with more than 4,000 who were not .\nFor patients on ventilators , it cut the risk of death from 40 % to 28 % .\nFor patients needing oxygen , it cut the risk of death from 25 % to 20 % .\nChief investigator Prof Peter Horby said : `` This is the only drug so far that has been shown to reduce mortality - and it reduces it significantly . It 's a major breakthrough . ''\nLead researcher Prof Martin Landray said the findings suggested one life could be saved for :\n`` The treatment is up to 10 days of dexamethasone and it costs about \u00a35 per patient .\nWhen appropriate , hospital patients should now be given it without delay , Prof Landray said .\nBut people should not go out and buy it to take at home .\nDexamethasone does not appear to help people with milder symptoms of coronavirus who do not need help with their breathing .\nSkip Twitter post by @ CMO_England This is the most important trial result for COVID-19 so far . Significiant reduction in mortality in those requiring oxygen or ventilation from a widely available , safe and well known drug . Many thanks to those who took part and made it happen . It will save lives around the world . https : //t.co/zRIaHulHOe \u2014 Professor Chris Whitty ( @ CMO_England ) June 16 , 2020 Report\nThe Recovery Trial , running since March , also looked at the malaria drug hydroxychloroquine , which has subsequently been ditched amid concerns it increases fatalities and heart problems .\nThe antiviral drug remdesivir , meanwhile , which appears to shorten recovery time for people with coronavirus , is already being made available on the NHS .\nThe first drug proven to cut deaths from Covid-19 is not some new , expensive medicine but an old , cheap-as-chips steroid .\nThat is something to celebrate because it means patients across the world could benefit immediately .\nAnd that is why the top-line results of this trial have been rushed out - because the implications are so huge globally .\nDexamethasone has been used since the early 1960s to treat a wide range of conditions , such as rheumatoid arthritis and asthma .\nHalf of all Covid patients who require a ventilator do not survive , so cutting that risk by a third would have a huge impact .\nThe drug is given intravenously in intensive care and in tablet form for less seriously ill patients .\nSo far , the only other drug proven to benefit Covid patients is remdesivir , which has been used for Ebola .\nThat has been shown to reduce the duration of coronavirus symptoms from 15 days to 11 .\nBut the evidence was not strong enough to show whether it reduced mortality .\nUnlike dexamethasone , remdesivir is a new drug with limited supplies and a price has yet to be announced .",
    "content_original": "Image copyright Getty Images\n\nA cheap and widely available drug can help save the lives of patients seriously ill with coronavirus.\n\nThe low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, UK experts say.\n\nThe drug is part of the world's biggest trial testing existing treatments to see if they also work for coronavirus.\n\nIt cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth.\n\nHad the drug had been used to treat patients in the UK from the start of the pandemic, up to 5,000 lives could have been saved, researchers say.\n\nMedia playback is unsupported on your device Media caption Katherine Millbank spent 15 days in hospital and was put on the drug trial\n\nAnd it could be of huge benefit in poorer countries with high numbers of Covid-19 patients.\n\nThe UK government has 200,000 courses of the drug in its stockpile and says the NHS will make dexamethasone available to patients.\n\nPrime Minister Boris Johnson said there was a genuine case to celebrate \"a remarkable British scientific achievement\", adding: \"We have taken steps to ensure we have enough supplies, even in the event of a second peak.\"\n\nChief Medical Officer for England Prof Chris Whitty said it would save lives around the world.\n\nAbout 19 out of 20 patients with coronavirus recover without being admitted to hospital.\n\nOf those who are admitted, most also recover but some may need oxygen or mechanical ventilation.\n\nAnd these are the high-risk patients dexamethasone appears to help.\n\nThe drug is already used to reduce inflammation in a range of other conditions, including arthritis, asthma and some skin conditions.\n\nAnd it appears to help stop some of the damage that can happen when the body's immune system goes into overdrive as it tries to fight off coronavirus.\n\nThis over-reaction, a cytokine storm, can be deadly.\n\nIn the trial, led by a team from Oxford University, about 2,000 hospital patients were given dexamethasone and compared with more than 4,000 who were not.\n\nFor patients on ventilators, it cut the risk of death from 40% to 28%.\n\nFor patients needing oxygen, it cut the risk of death from 25% to 20%.\n\nChief investigator Prof Peter Horby said: \"This is the only drug so far that has been shown to reduce mortality - and it reduces it significantly. It's a major breakthrough.\"\n\nLead researcher Prof Martin Landray said the findings suggested one life could be saved for:\n\nevery eight patients on a ventilator\n\nevery 20-25 treated with oxygen\n\n\"There is a clear, clear benefit,\" he said.\n\n\"The treatment is up to 10 days of dexamethasone and it costs about \u00a35 per patient.\n\n\"So essentially it costs \u00a335 to save a life.\n\n\"This is a drug that is globally available.\"\n\nWhen appropriate, hospital patients should now be given it without delay, Prof Landray said.\n\nBut people should not go out and buy it to take at home.\n\nDexamethasone does not appear to help people with milder symptoms of coronavirus who do not need help with their breathing.\n\nSkip Twitter post by @CMO_England This is the most important trial result for COVID-19 so far. Significiant reduction in mortality in those requiring oxygen or ventilation from a widely available, safe and well known drug. Many thanks to those who took part and made it happen. It will save lives around the world. https://t.co/zRIaHulHOe \u2014 Professor Chris Whitty (@CMO_England) June 16, 2020 Report\n\nThe Recovery Trial, running since March, also looked at the malaria drug hydroxychloroquine, which has subsequently been ditched amid concerns it increases fatalities and heart problems.\n\nThe antiviral drug remdesivir, meanwhile, which appears to shorten recovery time for people with coronavirus, is already being made available on the NHS.\n\nThe first drug proven to cut deaths from Covid-19 is not some new, expensive medicine but an old, cheap-as-chips steroid.\n\nThat is something to celebrate because it means patients across the world could benefit immediately.\n\nAnd that is why the top-line results of this trial have been rushed out - because the implications are so huge globally.\n\nDexamethasone has been used since the early 1960s to treat a wide range of conditions, such as rheumatoid arthritis and asthma.\n\nHalf of all Covid patients who require a ventilator do not survive, so cutting that risk by a third would have a huge impact.\n\nThe drug is given intravenously in intensive care and in tablet form for less seriously ill patients.\n\nSo far, the only other drug proven to benefit Covid patients is remdesivir, which has been used for Ebola.\n\nThat has been shown to reduce the duration of coronavirus symptoms from 15 days to 11.\n\nBut the evidence was not strong enough to show whether it reduced mortality.\n\nUnlike dexamethasone, remdesivir is a new drug with limited supplies and a price has yet to be announced.",
    "source_url": "www.bbc.com",
    "bias_text": "center",
    "ID": "CGjtOVX969ozD1UK"
}